Biogen Stock Touches 52-week Low at $183.55 Amid Market Challenges

Investing00:12

Scholar Rock Stock Quadruples on Positive Trial Data -- Barrons.com

Barron'sOct 7 23:05

Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year

BenzingaOct 7 22:23

Why Biogen Inc. (BIIB) Is a Top Value Stock for the Long-Term

Yahoo FinanceOct 7 21:40

Barclays Initiates Biogen(BIIB.US) With Hold Rating, Announces Target Price $190

Futu NewsOct 7 15:32 · Ratings

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Biogen (BIIB)

TipRanksOct 7 15:31 · Ratings